PDX Portal

Model Details

Patient Information for Model: TCH-HB01

Model Contact

Model: TCH-HB01
Model Contact: Sarah Woodfield
Institution: TCH Liver PDX Program
Email: sewoodfi@texaschildrens.org

Patient Information

Clinical Timeline

Color Keys:

Unknown

None

Low

Moderate

High

Very High

Clinical Information at Collection

Pathology Information at Collection

Model Information for Model: TCH-HB01

Model Details - Initial Implantation of Patient Tissue

Biomarkers & Mutations

Mutations (Cancer Gene Census List)

Mutation data is currently not available.

CNV

There are no omics data for this model.

Histology Information for Model: TCH-HB01

Metastasis Information for Model: TCH-HB01

Patient

PDX

Lung

Patient Treatment Information for Model: TCH-HB01

Event Id	Treatment	Treatment Setting	Age at Start	Age at End	Duration	Clinical Response	Pathologic Response
15	Cisplatin, 5-Fluorouracil/Vincristine	Neoadjuvant	1.09	1.12	11 days	No Response	No Response
25	Cisplatin, Doxorubicin	Neoadjuvant	1.14	1.24	37 days		Partial response